Tag: 2026
GSK Launches Tender Offer to Acquire Precision Oncology Innovator Nuvalent, Inc.at $124.00
GSK plc has officially commenced a tender offer to acquire all issued and outstanding shares of Class A and Class B common stock of Nuvalent,...
NPPA Launches Unified Digital Platform Integrating Pharma Jan Samadhan with Pharma Sahi Daam
In a major boost to citizen-centric digital governance, the National Pharmaceutical Pricing Authority (NPPA), Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, has officially...
Trodelvy Approved in Europe for Hard-to-Treat Breast Cancer Patients
The European Commission has granted marketing authorization for Trodelvy® (sacituzumabgovitecan) as an initial treatment for adults with unresectable or metastatic triple-negative breast cancer (mTNBC) who are ineligible...
FDA Reaches Out to Indian Pharma Amid Critical Ifosfamide Shortage in U.S.
A chemotherapy drug that stands between cancer patients and their treatment has gone dangerously scarce in the United States, compelling federal health regulators to...
Department of Pharmaceuticals urges Stakeholders to Submit Comments on Medical Device GTE Exemption List by July 15
The Department of Pharmaceuticals, under the Ministry of Chemicals and Fertilizers, has officially invited comments from stakeholders regarding proposed amendments to the Global Tender...
CDSCO Clarifies Approval Rules for Granules & Pellets, Bringing Regulatory Clarity to Pharma Industry
The Central Drugs Standard Control Organization (CDSCO), under the Directorate General of Health Services, has issued a comprehensive circular clarifying the regulatory and licensing...
